Why Women’s Sex Meds Are More Difficult

Why Women’s Sexual Health Medications Are So Challenging

Let’s state the obvious.

Medications for women’s sexual health are not as straightforward as the medications that address men’s sexual health. Erectile-dysfunction medications are simple and predictable. A man takes sildenafil or tadalafil, and within a clear window he either gets an erection or he doesn’t. The outcome is visible, measurable, and unmistakable.

Women’s sexual health medications do not work that way.

As of today, there are only two FDA-approved medications specifically for women’s low desire: Vyleesi (bremelanotide) and Addyi (flibanserin). Both have been shown to increase sexual desire in some women. And that phrase is important. These are not “female Viagra.” They work for a portion of women, and even then the effects are often subtle, contextual, or inconsistent.

⸻

Why?

Because sexual desire in women is influenced by far more variables than sexual performance in men.

ED medications do not create desire. They change blood flow. The results are immediate and obvious. But when women take something like Shamelessly Aroused (our topical sildenafil cream), Shameless Chemistry, oxytocin, Addyi, or Vyleesi, the results are internal and subjective. There is no appendage to visually confirm arousal. A woman may have increased sensitivity, lubrication, warmth, or mental interest — but none of these are as binary or visible as an erection.

This difference alone makes women’s medications far harder to evaluate, study, and approve.

⸻

Another challenge: hormones.

Women experience far more dramatic hormonal shifts in midlife than men do. Estrogen, progesterone, testosterone, and SHBG levels all change, and each of these influences desire, arousal, lubrication, pelvic-floor comfort, and overall sexual wellbeing. A woman going through perimenopause or menopause may have desire changes rooted in:

• hormonal fluctuations
• vaginal dryness
• painful penetration
• decreased lubrication
• sleep disruption
• mood changes
• stress and caregiving load

No single medication can override all of those factors at once, which is why expecting a universal “libido pill” for women is unrealistic.

Beyond hormones, women’s sexual desire is shaped by:

• emotional context
• relationship quality
• stress and fatigue
• body image
• mental load
• safety and comfort
• life stage

This does not mean desire is “complicated.” It means it is multidimensional.

So when a woman uses Addyi, Vyleesi, Shamelessly Aroused, Shameless Chemistry, or oxytocin nasal spray, the effect is real — but it interacts with a complex internal landscape. Some women notice a strong improvement. Some notice mild improvements. Some notice nothing. And all of these responses are normal.

This is why women’s sexual-health medications are challenging.
Not because they don’t work, but because women’s sexual desire is influenced by far more biological and psychological factors than men’s.

Women deserve sexual-health solutions that reflect this reality — not one-size-fits-all promises. That is why our approach focuses on multiple pathways: hormonal balance, arousal mechanisms, oxytocin-based bonding support, increased genital blood flow, education, and real clinical clarity.

⸻

Women’s sexual health is not simple.

But it is absolutely solvable when we stop pretending it should work like men’s — and start treating it with the depth, nuance, and respect it deserves.